Gola A., Silman D., Walters AA., Sridhar S., Uderhardt S., Salman AM., Halbroth BR., Bellamy D., Bowyer G., Powlson J., Baker M., Venkatraman N., Poulton I., Berrie E., Roberts R., Lawrie AM., Angus B., Khan SM., Janse CJ., Ewer KJ., Germain RN., Spencer AJ., Hill AVS.

A prime and target vaccine for liver-stage malaria results in sterile protection in mouse disease models and appears safe for human use.